Different pharmacological characteristics in L6 and C2C12 muscle cells and intact rat skeletal muscle for amylin, CGRP and calcitonin

British Journal of Pharmacology

Volumn 117, Issue 5, 1996, Pages 847-852

  Pittner, Richard A ^a   Wolfe Lopez, Deborah ^a   Young, Andrew A ^a   Beaumont, Kevin ^a  

^a AMYLIN PHARMACEUTICALS INC   (United States)

Author keywords

Amylin; Calcitonin; CGRP; Cyclic AMP; Glucose metabolism; L6; Peptide receptors; Skeletal muscle

Indexed keywords

ADENYLATE CYCLASE; AMYLIN; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CYCLIC AMP; GLYCOGEN; GLYCOGEN PHOSPHORYLASE; INSULIN; RECEPTOR; SALCATONIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN; CELL LINE; CONTROLLED STUDY; GLUCOSE METABOLISM; GLYCOGEN METABOLISM; MALE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE;

AMYLOID; ANIMALS; CALCITONIN; CALCITONIN GENE-RELATED PEPTIDE; CELL LINE; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCOGEN; MALE; MUSCLE, SKELETAL; PHOSPHORYLASES; RATS;

EID: 0030008121     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15270.x     Document Type: Article

References (31)

1. BEAUMONT, K., KENNEY, J.S., YOUNG, A.A. & RINK, T.J. (1993). High affinity amylin binding sites in rat brain. Mol. Pharmacol., 44, 493-497.
2. BEAUMONT, K., MOORE, C.X., PITTNER, R.A., CARLO, P., YOUNG, A.A., RINK, T.J., PRICKETT, K. & GAETA, L.S.L. (1995a). Blockade of amylin actions in rat skeletal muscle and in vivo by amylin receptor antagonists. Can. J. Physiol. Pharmacol., 72, 225.
3. BEAUMONT, K., PITTNER, R.A., MOORE, C.X., WOLFE-LOPEZ, D., PRICKETT, K.S., YOUNG, A.A. & RINK, T.J. (1995b). Regulation of muscle glycogen metabolism by CGRP and amylin: CGRP receptors not involved. Br. J. Pharmacol., 115, 713-715.
4. COOPER, G.J.S. (1994). Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. Endocr. Rev., 15, 163-201.
5. COOPER, G.J.S., LEIGHTON, B., DIMITRIADIS, G.D., PARRY-BILLINGS, M., KOWALCHUK, J.M., ROWLAND, K., ROTHBARD, J.B., WILLIS, A.C. & REID, K.B.M. (1988). Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. Proc. Natl. Acad. Sci. U.S.A., 85, 7763-7766.
6. DEEMS, R.O., CARDINAUX, F., DEACON, R.W. & YOUNG, D.A. (1991a). Amylin or CGRP (8-37) fragments reverse amylin-induced inhibition of 14C-glycogen accumulation. Biochem. Biophys. Res. Commun., 181, 116-120.
7. DEEMS, R.O., DEACON, R.W. & YOUNG, D.A. (1991b). Amylin activates glycogen phosphorylase and inactivates glycogen synthase via a cAMP-independent mechanism. Biochem. Biophys. Res. Commun., 174, 716-720.
8. HUE, L., BONTEMPS, F. & HERS, H.G. (1975). The effect of glucose and of potassium ions on the interconversion of the two forms of glycogen phosphorylase and of glycogen synthetase in isolated rat liver preparations. Biochem. J., 152, 105-114.
9. KREUTTER, D.K., ORENA, S.J. & ANDREWS, K.M. (1989). Suppression of insulin stimulated glucose transport in L6 myocytes by calcitonin gene related peptide. Biochem. Biophys. Res. Commun., 164, 461-467
10. KREUTTER, D.K., ORENA, S.J., TORCHIA, A.J., CONTILLO, L.G., ANDREWS, G.C. & STEVENSON, R.W. (1993). Amylin and CGRP induce insulin resistance via a receptor distinct from cAMP-coupled CGRP receptor. Am. J. Physiol., 264, E606-E613.
11. LAWRENCE, J.C. & ZHANG, J. (1994). Control of glycogen synthase and phosphorylase by amylin in rat skeletal muscle. Hormonal effects on the phosphorylation of phosphorylase and on the distribution of phosphate in the synthase subunit. J. Biol. Chem., 269, 11595-11600.
12. LEBEL, D., POIRER, G.G. & BEAUDOIN, A.R. (1978). A convenient method for the ATPase assay. Anal. Biochem., 85, 86-89.
13. LEIGHTON, B. & COOPER, G.J.S. (1988). Pancreatic amylin and CGRP cause resistance to insulin in skeletal muscle. Nature, 335, 632-635.
14. LEIGHTON, B., FOOT, E.A., COOPER, G.J.S. & KING, J.M. (1989). Calcitonin gene related peptide-1 (CGRP-1) is a potent regulator of glycogen metabolism in rat skeletal muscle. FEBS. Lett., 249, 357-361.
15. PITTNER, R.A., ALBRANDT, K., BEAUMONT, K., GAETA, L.S.L., KODA, J.E., MOORE, C.X., RITTENHOUSE, J. & RINK, T.J. (1994). Molecular physiology of amylin. J. Cell. Biochem., 55S, 19-28.
16. PITTNER, R.A., BEAUMONT, K., YOUNG, A.A. & RINK, T.J. (1995a). Dose-dependent elevation of cyclic AMP, activation of glycogen phosphorylase and release of lactate by amylin in rat skeletal muscle. Biochem. Biophys. Acta, (in press).
17. PITTNER, R.A., WOLFE-LOPEZ, D., YOUNG, A.A. & RINK, T.J. (1995b). Amylin and epinephrine have no direct effect on glucose transport in isolated rat soleus muscle. FEBS. Lett., 365, 98-100.
18. POYNER, D.R., ANDREW, D.P., BROWN, D., BOSE, C. & HANLEY, M.R. (1992). Pharmacological characterization of a receptor for calcitonin gene related peptide on rat L6 myocytes. Br. J. Pharmacol., 105, 441-447.
19. RINK, T.J., BEAUMONT, K., KODA, J.E. & YOUNG, A.A. (1993). Structure and biology of amylin. Trends Pharmacol. Sci., 14, 113-118.
20. ROSSETTI, L., FARRACE, S., CHOI, S.B., GIACCARI, A., SLOAN, L., FRONTONI, S. & KATZ, M.S. (1993). Multiple metabolic effects of GCRP in conscious rats: role of glycogen synthase and phosphorylase. Am. J. Physiol., 264, E1-E10.
21. SEXTON, P.M., PAXINOS, G., KENNEY, M.A. & BEAUMONT, K. (1994). In vitro autoradiographic localization of amylin binding sites in rat brain. Neurosci., 62, 553-567.
22. SHAINBERG, A., YAGIL, G. & YAFFE, D. (1971). Alterations of enzymatic activities during muscle differentiation in vitro. Dev. Biol., 25, 1-29.
23. SHERIFF, S., FISCHER, J.E. & BALASUBRAMANIAM, A. (1992). Amylin inhibits insulin-stimulated glucose uptake in C2C12 muscle cell line through a cholera-toxin-sensitive mechanism. Biochem. Biophys. Acta, 1136, 219-222.
24. STALMANS, W. & HERS, H.G. (1975). The stimulation of liver phosphorylase b by AMP, fluoride and sulfate. A technical note on the specific determination of the a and b forms of liver glycogen phosphorylase. Eur. J. Biochem., 54, 341-350.
25. VAN ROSSUM, D., MENARD, D.P., FOURNIER, A., STPIERRE, S. & QUIRION, R. (1994). Autoradiographic distribution and receptor binding profile of [I-125]Bolton Hunter-rat amylin binding sites in the rat brain. J. Pharmacol. Exp. Ther., 270, 779-787.
26. YAFFE, D. (1968). Retention of differentiation potentialities during prolonged cultivation of myogenic cells. Proc. Natl. Acad. Sci. U.S.A., 61, 477-483.
27. YAMAGUCHI, A., CHIBA, T., OKIMURA, Y., YAMATANI, T., MORISHITA, T., NAKAMURA, A., INUI, T., NODA, T. & FUJITA, T. (1988). Receptors for CGRP on the rat liver plasma membranes. Biochem. Biophys. Res. Commun., 152, 383-391.
28. YOUNG, A.A., GEDULIN, B., WOLFE-LOPEZ, D., GREEN, H.E., RINK, T.J. & COOPER, G.J.S. (1992). Amylin and insulin in rat soleus muscle: dose responses for cosecreted noncompetitive antagonists. Am. J. Physiol., 263, E274-E281.
29. YOUNG, A.A., WANG, M.W., GEDULIN, B., RINK, T.J., PITTNER, R.A. & BEAUMONT, K. (1995). 'Diabetogenic' effects of salmon calcitonin are attributable to amylin-like activity. Metabolism.
30. YOUNG, D.A., DEEMS, R.O., DEACON, R.W., MCINTOSH, R.H. & FOLEY, J.E. (1990). Effects of amylin on glucose metabolism and glycogenolysis in vivo and in vitro. Am. J. Physiol., 259, E457-E461.
31. ZHU, G., DUDLEY, D.T. & SALTIEL, A.R. (1991). Amylin increases cAMP formation in L6 myocytes through CGRP receptors. Biochem. Biophys. Res. Commun., 177, 771-776.